Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptophysin like 1 pseudogene 2 (SYPL1P2) is a human pseudogene annotated on chromosome 17. It is not a protein-coding gene and is not known to be transcribed or translated into a functional product. Unlike the protein-coding gene SYPL1 (synaptophysin-like protein 1), which is involved in synaptic vesicle trafficking and is associated with neurological disorders, SYPL1P2 lacks known function and is classified as a "pseudogene"—a category of gene relics that arise via duplication or mutation and are generally non-functional[2][6]. There are no known disease associations, molecular functions, or drug interactions specific to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptophysin like 1 pseudogene 2 (SYPL1P2).